EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Electrophysiological study of the antiarrhythmic activity of delagil and its blocking effect in patients with paroxysmal atrial arrhythmia


Kardiologiya 28(2): 77-78
Electrophysiological study of the antiarrhythmic activity of delagil and its blocking effect in patients with paroxysmal atrial arrhythmia
The electrophysiological activity of delagil was studied in sixty-four patients with hypertension, idiopathic atrial arrhythmia, postmyocarditic cardiosclerosis, alcoholic cardiomyopathy, rheumatic heart diseases, and thyrotoxicosis following intravenous administration. Complications and side effects were noted in 25 patients, but in 20 cases they were only temporary (5-10 minutes). The effect of delagil on arterial pressure and ECG was also studied. In most patients, delagil was found to be an effective preparation in the prevention of paroxysmal atrial arrhythmia, and was well tolerated.


Accession: 005349848



Related references

Electrophysiological study of the anti-arrhythmic activity of delagil and its modifying effect in patients with paroxysmal atrial fibrillation. Kardiologiia 28(2): 77-78, 1988

Canine digitalis arrhythmia as a model for detecting sodium channel blocking antiarrhythmic drugs a comparative study using other canine arrhythmia models and the new antiarrhythmic drugs propafenone tocainide and sun 1165. Heart & Vessels 1(1): 29-35, 1985

Canine digitalis arrhythmia as a model for detecting Na-channel blocking antiarrhythmic drugs: a comparative study using other canine arrhythmia models and the new antiarrhythmic drugs, propafenone, tocainide, and SUN 1165. Heart and Vessels 1(1): 29-35, 1985

Effect of antiarrhytmic drugs on the atrial arrhythmia cycle length in patients affected by paroxysmal atrial fibrillation Italian AT500 registry. European Heart Journal 22(Abstract Supplement): 327, September, 2001

Is an electrophysiological study useful for the choice of anti-arrhythmia drug in patients with supraventricular paroxysmal tachycardia?. Giornale Italiano di Cardiologia 9(5): 458-461, 1979

Effect of combined antiarrhythmic drugs in patients with paroxysmal atrial fibrillation. Terapevticheskii Arkhiv 64(4): 51-55, 1992

Serial testing of anti-arrhythmia preparations using the intracardiac electrophysiological study of patients with reciprocal paroxysmal tachycardias. Kardiologiia 26(11): 30-35, 1986

Patients with paroxysmal atrial fibrillation but not paroxysmal supraventricular tachycardia display evidence of platelet activation during arrhythmia. Platelets 14(7-8): 407-411, 2004

Antiarrhythmic effect of bisoprolol, a highly selective beta1-blocker, in patients with paroxysmal atrial fibrillation. International Heart Journal 49(3): 281-293, 2008

Effect of clonazepam and antiarrhythmic drugs on heart rate variability in patients with paroxysmal atrial fibrillation. Kardiologiia 45(1): 35-40, 2005